BIOS VS CFFS Stock Comparison

PerformanceAnalyst Price TargetsProfitVolatility
PerformanceAnalyst Price TargetsProfitVolatility

Performance

BIOS
100/100

BIOS returned 7.25% in the last 12 months. Based on SPY's performance of -3.02%, its performance is above average giving it a score of 100 of 100.

CFFS
100/100

CFFS returned 7.30% in the last 12 months. Based on SPY's performance of 0.06%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

BIOS
88/100

6 analysts offer 12-month price targets for BIOS. Together, they have an average target of 0, the most optimistic target put BIOS at 0 within 12-months and the most pessimistic has BIOS at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

CFFS

"Analyst Price Targets" not found for CFFS

Profit

BIOS
12/100

Out of the last 20 quarters, BIOS has had 4 profitable quarters and has increased their profits year over year on 0 of them.

CFFS
62/100

Out of the last 11 quarters, CFFS has had 5 profitable quarters and has increased their profits year over year on 5 of them.

Volatility

BIOS
10/100

BIOS has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.

CFFS
18/100

CFFS has had a lower than average amount of volatility over the last 12 months giving it a score of 18 of 100.

All score calculations are broken down here to help you make more informed investing decisions

BioPlus Acquisition Corp. Class A Ordinary Shares Summary

Nasdaq / BIOS
Financial Services
Shell Companies
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

CF Acquisition Corp. VII Class A Common Stock Summary

Nasdaq / CFFS
Financial Services
Shell Companies
CF Acquisition Corp. VII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on potential target companies in the financial services, healthcare, real estate services, technology, and software industries. CF Acquisition Corp. VII was incorporated in 2020 and is based in New York, New York.